Health Care

Profit & Loss

($) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue 19,064,123,000 15,982,643,000 14,672,271,000 13,456,671,000 12,044,943,000 5,017,720,000 4,200,525,000 3,913,475,000 3,484,073,000 3,345,616,000
Cost of Goods Sold -6,083,531,000 -5,041,773,000 -4,756,488,000 -4,449,811,000 -4,149,808,000 -811,666,000 -650,956,000 -596,973,000 -525,231,000 -1,522,717,000
Gross Profit 12,980,592,000 10,940,870,000 9,915,783,000 9,006,860,000 7,895,135,000 4,206,054,000 3,549,569,000 3,316,502,000 2,958,842,000 1,822,899,000
Operating Costs -7,929,480,000 -7,412,456,000 -6,603,463,000 -5,931,135,000 -5,482,356,000 -3,541,272,000 -3,030,326,000 -2,740,826,000 -2,450,455,000 -1,328,007,000
Operating Profit 5,051,112,000 3,528,414,000 3,312,320,000 3,075,725,000 2,412,779,000 664,782,000 519,243,000 575,676,000 508,387,000 494,892,000
Financing Costs -259,419,000 -256,651,000 -248,963,000 -177,544,000 -147,236,000 -67,137,000 -55,928,000 -60,710,000 -65,147,000 -76,964,000
Pre Tax Profit 5,051,112,000 3,528,414,000 3,312,320,000 3,075,725,000 2,412,779,000 664,782,000 519,243,000 575,676,000 508,387,000 494,892,000
Income Tax -1,069,035,000 -627,360,000 -585,588,000 -684,216,000 -485,723,000 -131,644,000 -109,278,000 -126,106,000 -103,572,000 -100,243,000
Profit 3,722,658,000 2,644,403,000 2,477,769,000 2,213,965,000 1,779,820,000 466,001,000 354,037,000 388,860,000 339,668,000 317,685,000

Balance Sheet

($) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Current Assets 9,674,273,000 8,901,305,000 7,293,284,000 6,225,409,000 5,904,543,000 1,136,753,000 1,019,702,000 913,019,000 852,465,000 714,756,000
Non Current Assets 20,243,618,000 18,690,525,000 14,980,950,000 12,750,025,000 11,096,322,000 6,233,866,000 5,329,003,000 4,884,587,000 4,665,761,000 4,214,049,000
Assets 29,917,891,000 27,591,830,000 22,274,234,000 18,975,434,000 17,000,865,000 7,370,619,000 6,348,705,000 5,797,606,000 5,518,226,000 4,928,805,000
Current Liabilities 5,321,537,000 4,211,633,000 4,037,584,000 2,782,563,000 3,231,748,000 1,220,439,000 588,306,000 1,021,194,000 1,024,639,000 981,435,000
Non Current Liabilities 9,710,711,000 11,188,299,000 7,493,484,000 7,830,046,000 6,679,187,000 2,417,471,000 2,434,401,000 1,667,418,000 1,575,486,000 1,337,171,000
Liabilities 15,032,248,000 15,399,932,000 11,531,068,000 10,612,609,000 9,910,935,000 3,637,910,000 3,022,707,000 2,688,612,000 2,600,125,000 2,318,606,000
Equity 14,885,643,000 12,191,898,000 10,743,166,000 8,362,825,000 7,089,930,000 3,732,709,000 3,325,998,000 3,108,994,000 2,918,101,000 2,610,199,000

Cash Flow

($) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Cash Flow from Operating Activities 5,664,736,000 3,848,598,000 2,491,708,000 2,670,020,000 1,982,965,000 707,708,000 512,084,000 556,358,000 459,459,000 486,758,000
Cash Flow from Financing Activities -3,356,458,000 -1,179,436,000 196,166,000 -804,919,000 -14,942,000 131,849,000 -219,347,000 -210,280,000 -175,151,000 -154,112,000
Cash Flow from Investing Activities -2,059,950,000 -1,701,617,000 -2,386,629,000 -1,998,536,000 -1,536,392,000 -786,237,000 -288,989,000 -339,370,000 -258,584,000 -335,736,000
Cash Flow 248,328,000 967,545,000 301,245,000 -133,435,000 431,631,000 53,320,000 3,748,000 6,708,000 25,724,000 -3,090,000
Foreign Exchange Movements 150,000 19,458,000 -32,767,000 -21,214,000 3,250,000 -12,277,000 13,508,000 5,700,000 25,411,000 -3,003,000
Cash at the Beginning of the Period 2,381,449,000 1,394,446,000 1,125,968,000 1,280,617,000 845,736,000 249,393,000 232,137,000 219,729,000 168,594,000 174,687,000
Cash at the End of the Period 2,629,927,000 2,381,449,000 1,394,446,000 1,125,968,000 1,280,617,000 290,436,000 249,393,000 232,137,000 219,729,000 168,594,000

Profitability

(%) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Gross Margin 68.1 68.5 67.6 66.9 65.5 83.8 84.5 84.7 84.9 54.5
Operating Margin 26.5 22.1 22.6 22.9 20.0 13.2 12.4 14.7 14.6 14.8
Profit Margin 19.5 16.5 16.9 16.5 14.8 9.3 8.4 9.9 9.7 9.5

Management Effectiveness

  2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Return on Assets (%) 12.4 9.6 11.1 11.7 10.5 6.3 5.6 6.7 6.2 6.4
Return on Equity (%) 25.0 21.7 23.1 26.5 25.1 12.5 10.6 12.5 11.6 12.2
Current Ratio 1.8 2.1 1.8 2.2 1.8 0.9 1.7 0.9 0.8 0.7
Debt to Equity Ratio 1.0 1.3 1.1 1.3 1.4 1.0 0.9 0.9 0.9 0.9

Valuation

  2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Share Price ($) 158.78 155.80 118.94 111.23 83.36 21.55 21.37 17.33 14.81 12.70
Ordinary Shares 933,047,064 929,225,088 927,095,036 877,105,775 872,650,218 415,089,808 401,991,556 400,811,556 397,158,181 390,969,875
Market Capitalisation ($) 148,150,173,968 144,771,596,183 110,269,024,428 97,559,452,443 72,743,214,993 8,945,185,362 8,590,559,552 6,946,064,265 5,881,912,661 4,965,317,413
Revenue per Share ($) 20.43 17.20 15.83 15.34 13.80 12.09 10.45 9.76 8.77 8.56
Earnings per Share ($) 3.99 2.85 2.67 2.52 2.04 1.12 0.88 0.97 0.86 0.81
Dividends per Share ($) 1.48 1.39 1.27 1.04 1.01 0.53 0.70 0.65 0.52 0.59
Dividend Yield (%) 0.9 0.9 1.1 0.9 1.2 2.5 3.3 3.7 3.5 4.7
Price to Sales Ratio 7.8 9.1 7.5 7.2 6.0 1.8 2.0 1.8 1.7 1.5
Price to Earnings Ratio 39.8 54.7 44.5 44.1 40.9 19.2 24.3 17.9 17.3 15.6
Price to Book Ratio 10.0 11.9 10.3 11.7 10.3 2.4 2.6 2.2 2.0 1.9